范可尼贫血患者异基因骨髓移植后发生格雷夫斯眼眶病——是阿仑单抗治疗的副作用吗？
Graves' orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia - side effect of alemtuzumab therapy?
作者信息
Cima Luminita Nicoleta, Lambrescu Ioana Maria, Stejereanu Lavinia, Colita Anca, Or Reuven, Fica Simona
机构信息
Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania.
Carol Davila University of Medicine and Pharmacy Bucharest Romania.
出版信息
Clin Case Rep. 2018 Mar 12;6(5):867-870. doi: 10.1002/ccr3.1486. eCollection 2018 May.
Abstract
A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves' orbitopathy after alemtuzumab conditioning for hematopoietic stem cell transplantation.
摘要
在多发性硬化症患者中，已有几例使用阿仑单抗治疗后出现甲状腺眼病的病例报道。我们的患者是首例在接受阿仑单抗预处理进行造血干细胞移植后发生格雷夫斯眼眶病的病例。
Zotero 插件